Effects of the expansion of doctors' offices adjacent to private pharmacies in Mexico: secondary data analysis of a national survey
- PMID: 24852298
- PMCID: PMC4039785
- DOI: 10.1136/bmjopen-2013-004669
Effects of the expansion of doctors' offices adjacent to private pharmacies in Mexico: secondary data analysis of a national survey
Abstract
Objectives: To compare the sociodemographic characteristics, reasons for attending, perception of quality and associated out-of-pocket (OOP) expenditures of doctors' offices adjacent to private pharmacies (DAPPs) users with users of Social Security (SS), Ministry of Health (MoH), private doctor's offices independent from pharmacies and non-users.
Setting: Secondary data analysis of the 2012 National Survey of Health and Nutrition of Mexico.
Participants: The study population comprised 25 852 individuals identified as having had a health problem 15 days before the survey, and a random sample of 12 799 ambulatory health service users.
Outcome measures: Sociodemographic characteristics, reasons for attending healthcare services, perception of quality and associated OOP expenditures.
Results: The distribution of users was as follows: DAPPs (9.2%), SS (16.1%), MoH (20.9%), private providers (15.4%) and non-users (38.5%); 65% of DAPP users were affiliated with a public institution (MoH 35%, SS 30%) and 35% reported not having health coverage. DAPP users considered the services inexpensive, convenient and with a short waiting time, yet they received ≥3 medications more often (67.2%, 95% CI 64.2% to 70.1%) than users of private doctors (55.7%, 95% CI 52.5% to 58.6%) and public institutions (SS 53.8%, 95% CI 51.6% to 55.9%; MoH 44.7%, 95% CI 42.5% to 47.0%). The probability of spending on consultations (88%, 95% CI 86% to 89%) and on medicines (97%, 95% CI 96% to 98%) was much higher for DAPP users when compared with SS (2%, 95% CI 2% to 3% and 12%, 95% CI 11% to 14%, respectively) and MoH users (11%, 95% CI 9% to 12% and 32%, 95% CI 30% to 34%, respectively).
Conclusions: DAPPs counteract current financial protection policies since a significant percentage of their users were affiliated with a public institution, reported higher OOP spending and higher number of medicines prescribed than users of other providers. The overprescription should prompt studies to learn about DAPPs' quality of care, which may arise from the conflict of interest implicit in the linkage of prescribing and dispensing processes.
Keywords: Primary Care.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Similar articles
-
Doctors Adjacent to Private Pharmacies: The New Ambulatory Care Provider for Mexican Health Care Seekers.Value Health Reg Issues. 2017 Dec;14:81-88. doi: 10.1016/j.vhri.2017.08.010. Value Health Reg Issues. 2017. PMID: 29254546
-
Users' perception of quality as a driver of private healthcare use in Mexico: Insights from the People's Voice Survey.PLoS One. 2024 Jun 25;19(6):e0306179. doi: 10.1371/journal.pone.0306179. eCollection 2024. PLoS One. 2024. PMID: 38917130 Free PMC article.
-
Ambulatory health service users' experience of waiting time and expenditure and factors associated with the perception of low quality of care in Mexico.BMC Health Serv Res. 2010 Jun 23;10:178. doi: 10.1186/1472-6963-10-178. BMC Health Serv Res. 2010. PMID: 20573225 Free PMC article.
-
Mexico: Health System Review.Health Syst Transit. 2020 Apr;22(2):1-222. Health Syst Transit. 2020. PMID: 33527902 Review.
-
Hong Kong's domestic health spending--financial years 1989/90 through 2004/05.Hong Kong Med J. 2008 Apr;14 Suppl 2:2-23. Hong Kong Med J. 2008. PMID: 18587162 Review.
Cited by
-
Healthcare System Distrust and Non-Prescription Antibiotic Use: A Cross-Sectional Survey of Adult Antibiotic Users.Antibiotics (Basel). 2023 Jan 1;12(1):79. doi: 10.3390/antibiotics12010079. Antibiotics (Basel). 2023. PMID: 36671280 Free PMC article.
-
All-cause mortality among patients treated with repurposed antivirals and antibiotics for COVID-19 in Mexico City: A real-world observational study.EXCLI J. 2021 Feb 4;20:199-222. doi: 10.17179/excli2021-3413. eCollection 2021. EXCLI J. 2021. PMID: 33628159 Free PMC article.
-
Advances and challenges on the path toward the SDGs: subnational inequalities in Mexico, 1990-2017.BMJ Glob Health. 2020 Oct;5(10):e002382. doi: 10.1136/bmjgh-2020-002382. BMJ Glob Health. 2020. PMID: 33122296 Free PMC article.
-
Barriers and opportunities to improve the foundations for high-quality healthcare in the Mexican Health System.Health Policy Plan. 2018 Dec 1;33(10):1073-1082. doi: 10.1093/heapol/czy098. Health Policy Plan. 2018. PMID: 30544258 Free PMC article.
-
["What choice do people have other than us?": The role of doctors' offices adjacent to private pharmacies in the Covid-19 pandemic].Salud Colect. 2023 Mar 16;19:e4280. doi: 10.18294/sc.2023.4280. Salud Colect. 2023. PMID: 37311142 Free PMC article. Spanish.
References
-
- Organisation for Economic Co-operation and Development. OECD Health Data 2013: how does Mexico compare. Organisation for Economic Co-operation and Development, 2013. http://www.oecd.org/mexico/Briefing-Note-MEXICO-2013.pdf
-
- Organisation for Economic Co-operation and Development. An overview of growing income inequalities in OECD countries: main findings. Organisation for Economic Co-operation and Development, 2011. http://www.oecd.org/els/soc/49499779.pdf
-
- Wirtz VJ, Reich MR, Leyva-Flores R, et al. Medicines in Mexico, 1990–2004: systematic review of research on access and use. Salud Publica Mex 2008;50:S470–9 - PubMed
-
- Knaul FM, González-Pier E, Gómez-Dantés O, et al. The quest for universal health coverage: achieving social protection for all in Mexico. Lancet 2012;380:1259–79 - PubMed
-
- Fundación Mexicana para la Salud: Trabajando por la salud de la población. Propuestas de política para el sector farmacéutico. Versión para el diálogo. FUNSALUD, A. C., 2011. http://www.funsalud.org.mx/eventos_2011/trabajando%20por%20la%20salud/Do...
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases